ciprofloxacin has been researched along with Bacteriuria in 63 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Bacteriuria: The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 9.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "To determine the efficacy of prophylactic ciprofloxacin in preventing urinary tract infections caused by urodynamic study (UDS)." | 9.12 | Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. ( Kale, M; Kartal, ED; Kiremitci, A; Meric, H; Usluer, G; Yenilmez, A, 2006) |
| "The rate of bacteriuria after FC was reduced from 9% in the placebo group to 5% and 3% in patients receiving trimethoprim and ciprofloxacin prophylaxis, respectively." | 9.12 | Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. ( Johnson, MI; Lennon, T; Masters, J; Matthews, JN; Merrilees, D; Neal, DE; Orr, KE; Robson, WA, 2007) |
| "Ciprofloxacin is considered to be the standard treatment for patients with complicated urinary tract infections (UTI)." | 9.09 | Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. ( Krcmery, S; Naber, KG, 1999) |
| "As urinary tract infections in immunosuppressed renal transplant patients present a major therapeutic problem for clinicians in charge of renal units, the efficacy of the antibiotic ciprofloxacin in such cases was tested in this study." | 7.68 | Treatment of urinary tract infections with ciprofloxacin after renal transplantation. ( Alivanis, P; Dioudis, C; Grekas, D; Thanos, V; Tourkantonis, A, 1993) |
| "In an open study, a group of 11 patients with asymptomatic urinary tract infections, caused by resistant Pseudomonas strains, were given 200 mg of ciprofloxacin per day for 1 week." | 7.67 | Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin. ( Chysky, V; Dammekens, H; Van Poppel, H; Wegge, M, 1986) |
| "Sulopenem followed by oral sulopenem-etzadroxil/probenecid was not noninferior to ertapenem followed by oral step-down therapy for the treatment of cUTIs, driven by a lower rate of asymptomatic bacteriuria in those who received ciprofloxacin." | 5.69 | Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial. ( Akinapelli, K; Aronin, SI; Breen, J; Das, AF; Dunne, MW; Puttagunta, S; Zelasky, MT, 2023) |
| "Oral treatment with ciprofloxacin is an alternative to parenteral antibiotics in SCL-patients with urinary tract infection caused by resistant bacteria." | 5.28 | Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria. ( Biering-Sørensen, F; Høiby, N; Hørbov, S; Pedersen, SS, 1990) |
| "The aim of this study was to assess the efficacy of prophylactic fosfomycin tromethamine (FT) and ciprofloxacin in preventing bacteriuria caused by urodynamic studies (UDS)." | 5.17 | Are prophylactic antibiotics necessary for urodynamic study? ( Atış, G; Canat, L; Caşkurlu, T; Güner, B; Gürbüz, C, 2013) |
| "In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged ≥18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days." | 5.16 | Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. ( Ekman, GS; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergård, A; Otto, G; Sandberg, T; Settergren, B; Skoog, G, 2012) |
| "To determine the efficacy of prophylactic ciprofloxacin in preventing urinary tract infections caused by urodynamic study (UDS)." | 5.12 | Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. ( Kale, M; Kartal, ED; Kiremitci, A; Meric, H; Usluer, G; Yenilmez, A, 2006) |
| "The objective of this multicenter, randomized, controlled, parallel group trial was to evaluate the efficacy of levofloxacin 250 mg oral, once daily (LVFX), placebo one tablet oral once daily (Placebo [P] group) and ciprofloxacin (CPFX) 500 mg oral, twice daily (single blind), prophylaxis in preventing bacteriuria (> or = 10(3) CFU/ml) in post-surgical catheterized patients." | 5.12 | A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones. ( Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S, 2006) |
| "Ciprofloxacin is considered to be the standard treatment for patients with complicated urinary tract infections (UTI)." | 5.09 | Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. ( Krcmery, S; Naber, KG, 1999) |
| "To determine the efficacy and safety of single-dose oral ciprofloxacin prophylaxis for the prevention of post-operative bacteriuria following transurethral resection of the prostate or bladder tumour, a prospective, randomized, double-blind, placebo-controlled trial was conducted." | 5.09 | Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery. ( Cox, CE; Echols, RM; Klimberg, IW; Kowalsky, SF; Malek, GH; Patterson, AL; Whalen, E, 1999) |
| "A double-blind, randomised, placebo-controlled study was carried out to determine the incidence and significance of bacteriuria in 110 patients undergoing transurethral resection of the prostate (TURP) and to assess the effect of a single pre-operative dose of Ciprofloxacin, a 4-quinolone antibiotic." | 5.06 | Single dose, oral antibiotic cover for transurethral prostatectomy. ( Burdon, DW; Farrar, DJ; Johnson, M; Keighley, MR; Shearman, CP; Silverman, SH; Young, CH, 1988) |
| " However, although a single treatment of chitosan followed by ciprofloxacin administration had a marked effect on reducing UPEC titers within the bladder, this treatment failed to prevent relapsing bacteriuria." | 3.85 | Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders. ( Blango, MG; Erman, A; Hergouth, VK; Kos, MK; Mulvey, MA; Veranic, P, 2017) |
| "Fosfomycin is recommended as first-line treatment for acute uncomplicated cystitis in women." | 3.81 | Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates. ( Eliopoulos, GM; Hirsch, EB; Kim, Y; Kirby, JE; McCoy, C; Raux, BR; Wright, SB; Zucchi, PC, 2015) |
| "As urinary tract infections in immunosuppressed renal transplant patients present a major therapeutic problem for clinicians in charge of renal units, the efficacy of the antibiotic ciprofloxacin in such cases was tested in this study." | 3.68 | Treatment of urinary tract infections with ciprofloxacin after renal transplantation. ( Alivanis, P; Dioudis, C; Grekas, D; Thanos, V; Tourkantonis, A, 1993) |
| "In an open study, a group of 11 patients with asymptomatic urinary tract infections, caused by resistant Pseudomonas strains, were given 200 mg of ciprofloxacin per day for 1 week." | 3.67 | Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin. ( Chysky, V; Dammekens, H; Van Poppel, H; Wegge, M, 1986) |
| "Ciprofloxacin is an investigational quinolone agent possessing an impressive antibacterial spectrum." | 2.66 | The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin. ( Brittain, DC; Labthavikul, P; McElrath, MJ; Neu, HC; Scully, BE; Steinman, R, 1985) |
| "Ciprofloxacin was well tolerated and no significant haematological or biochemical side effects were detected." | 2.66 | Oral ciprofloxacin as prophylaxis in transurethral resection of the prostate. ( Badenoch, DF; Gatchalian, ER; Murdoch, DA, 1987) |
| "Bacteriuria was treated with the pre-operative single dose of 1." | 1.48 | Peri-operative antibiotic treatment of bacteriuria reduces early deep surgical site infections in geriatric patients with proximal femur fracture. ( Bushuven, S; Langenhan, R; Probst, A; Reimers, N, 2018) |
| "Bacteriuria was present in 15% of the patients in Group 1, compared to 22." | 1.46 | The Effect of Antibiotic Prophylaxis on Post-Operative Infection in Patients Undergone Flexible Cystos-copy. ( Arrabal-Martín, M; Arrabal-Polo, MA; Cano-García, MDC; Merino-Salas, S, 2017) |
| "Bacteriuria was present in 9% of the subjects." | 1.40 | Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh. ( Ahmed, MF; Begum, A; Rahman, SR, 2014) |
| "Ciprofloxacin resistance was identified in 18% and 6% of consecutively collected, clinically significant urinary tract isolates of Escherichia coli from inpatients and outpatients, respectively." | 1.33 | Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. ( Drews, SJ; Green, K; Low, DE; Mazzulli, T; McGeer, AJ; Pong-Porter, S; Poutanen, SM; Rzayev, Y; Sarabia, A; Willey, B, 2005) |
| " Enoxacin (250 mg/l) demonstrated the highest peak concentration (median) in the urine (0-6 h), followed by ciprofloxacin (237 mg/l) and norfloxacin (157 mg/l) as determined by the HPLC assay." | 1.30 | Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose. ( Kinzig-Schippers, M; Naber, KG; Sörgel, F; Well, M, 1998) |
| "Oral treatment with ciprofloxacin is an alternative to parenteral antibiotics in SCL-patients with urinary tract infection caused by resistant bacteria." | 1.28 | Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria. ( Biering-Sørensen, F; Høiby, N; Hørbov, S; Pedersen, SS, 1990) |
| " Ciprofloxacin's in vitro activity and human pharmacology should permit a twice or once-daily dosing schedule for systemic infections due to most Enterobacteriaceae, Haemophilus, Branhamella and Pseudomonas and S." | 1.27 | The pharmacology of orally administered ciprofloxacin. ( Brittain, DC; Labthavikul, P; McElrath, MJ; Neu, HC; Scully, BE; Steinman, R, 1985) |
| "Ciprofloxacin (Bay o9867) is a new quinolone derivative." | 1.27 | Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates. ( Piccolomini, R; Ravagnan, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (19.05) | 18.7374 |
| 1990's | 18 (28.57) | 18.2507 |
| 2000's | 12 (19.05) | 29.6817 |
| 2010's | 18 (28.57) | 24.3611 |
| 2020's | 3 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Dunne, MW | 1 |
| Aronin, SI | 1 |
| Das, AF | 1 |
| Akinapelli, K | 1 |
| Breen, J | 1 |
| Zelasky, MT | 1 |
| Puttagunta, S | 1 |
| Islam, MA | 1 |
| Alam, SM | 1 |
| Reza, AM | 1 |
| Soucy, JR | 1 |
| Schmidt, AM | 1 |
| Quach, C | 1 |
| Buckeridge, DL | 1 |
| Arrabal-Polo, MA | 2 |
| Cano-García, MDC | 1 |
| Arrabal-Martín, M | 2 |
| Merino-Salas, S | 2 |
| Qi, DZ | 1 |
| Lehman, K | 1 |
| Dewan, K | 1 |
| Kirimanjeswara, G | 1 |
| Raman, JD | 1 |
| O'Halloran, C | 1 |
| Walsh, N | 1 |
| O'Grady, MC | 1 |
| Barry, L | 1 |
| Hooton, C | 1 |
| Corcoran, GD | 1 |
| Lucey, B | 1 |
| Langenhan, R | 1 |
| Bushuven, S | 1 |
| Reimers, N | 1 |
| Probst, A | 1 |
| Prah, JK | 1 |
| Amoah, S | 1 |
| Ocansey, DW | 1 |
| Arthur, R | 1 |
| Walker, E | 1 |
| Obiri-Yeboah, D | 1 |
| Gürbüz, C | 1 |
| Güner, B | 1 |
| Atış, G | 1 |
| Canat, L | 1 |
| Caşkurlu, T | 1 |
| Rahman, SR | 1 |
| Ahmed, MF | 1 |
| Begum, A | 1 |
| MacFadden, DR | 1 |
| Ridgway, JP | 1 |
| Robicsek, A | 1 |
| Elligsen, M | 1 |
| Daneman, N | 1 |
| Cano-García, Mdel C | 1 |
| Casares-Pérez, R | 1 |
| Castillo-Gallardo, E | 1 |
| Hirsch, EB | 1 |
| Raux, BR | 1 |
| Zucchi, PC | 1 |
| Kim, Y | 1 |
| McCoy, C | 1 |
| Kirby, JE | 1 |
| Wright, SB | 1 |
| Eliopoulos, GM | 1 |
| Süzük, S | 1 |
| Kaşkatepe, B | 1 |
| Avcıküçük, H | 1 |
| Aksaray, S | 1 |
| Başustaoğlu, A | 1 |
| Erman, A | 1 |
| Hergouth, VK | 1 |
| Blango, MG | 1 |
| Kos, MK | 1 |
| Mulvey, MA | 1 |
| Veranic, P | 1 |
| Briffaux, R | 1 |
| Coloby, P | 1 |
| Bruyere, F | 1 |
| Ouaki, F | 1 |
| Pires, C | 1 |
| Doré, B | 1 |
| Irani, J | 1 |
| Song, S | 1 |
| Lee, EY | 1 |
| Koh, EM | 1 |
| Ha, HS | 1 |
| Jeong, HJ | 1 |
| Bae, IK | 1 |
| Jeong, SH | 1 |
| Nicoletti, J | 1 |
| Kuster, SP | 1 |
| Sulser, T | 1 |
| Zbinden, R | 1 |
| Ruef, C | 1 |
| Ledergerber, B | 1 |
| Weber, R | 1 |
| van Hees, BC | 1 |
| Vijverberg, PL | 1 |
| Hoorntje, LE | 1 |
| Wiltink, EH | 1 |
| Go, PM | 1 |
| Tersmette, M | 1 |
| Utrera, NM | 1 |
| Álvarez, MB | 1 |
| Polo, JM | 1 |
| Sánchez, AT | 1 |
| Martínez, JP | 1 |
| González, RD | 1 |
| Hoshide, RR | 1 |
| Chung, H | 1 |
| Tokeshi, J | 1 |
| Sandberg, T | 1 |
| Skoog, G | 1 |
| Hermansson, AB | 1 |
| Kahlmeter, G | 1 |
| Kuylenstierna, N | 1 |
| Lannergård, A | 1 |
| Otto, G | 1 |
| Settergren, B | 1 |
| Ekman, GS | 1 |
| Nicolle, LE | 1 |
| Veliev, EI | 1 |
| Jureen, R | 1 |
| Digranes, A | 1 |
| Baerheim, A | 1 |
| Meiland, R | 1 |
| Geerlings, SE | 1 |
| De Neeling, AJ | 1 |
| Hoepelman, AI | 1 |
| Drews, SJ | 1 |
| Poutanen, SM | 1 |
| Mazzulli, T | 1 |
| McGeer, AJ | 1 |
| Sarabia, A | 1 |
| Pong-Porter, S | 1 |
| Rzayev, Y | 1 |
| Willey, B | 1 |
| Green, K | 1 |
| Low, DE | 1 |
| Johnson, JR | 1 |
| Kartal, ED | 1 |
| Yenilmez, A | 1 |
| Kiremitci, A | 1 |
| Meric, H | 1 |
| Kale, M | 1 |
| Usluer, G | 1 |
| Esposito, S | 2 |
| Noviello, S | 1 |
| Leone, S | 1 |
| Marvaso, A | 1 |
| Drago, L | 1 |
| Marchetti, F | 1 |
| Johnson, MI | 1 |
| Merrilees, D | 1 |
| Robson, WA | 1 |
| Lennon, T | 1 |
| Masters, J | 1 |
| Orr, KE | 1 |
| Matthews, JN | 1 |
| Neal, DE | 1 |
| Hori, S | 1 |
| Kennedy, CL | 1 |
| Preskorn, SH | 1 |
| Amyes, SG | 1 |
| Baird, DR | 1 |
| Crook, DW | 1 |
| Gillespie, SH | 1 |
| Howard, AJ | 1 |
| Oppenhiem, BA | 1 |
| Pedler, SJ | 1 |
| Paull, A | 1 |
| Tompkins, DS | 1 |
| Lawrie, SA | 1 |
| Grekas, D | 1 |
| Thanos, V | 1 |
| Dioudis, C | 1 |
| Alivanis, P | 1 |
| Tourkantonis, A | 1 |
| Bijl, W | 1 |
| Janknegt, RA | 1 |
| Loran, OB | 1 |
| Pushkar', DIu | 1 |
| Tevlin, KP | 1 |
| Moysés Neto, M | 1 |
| Costa, RS | 1 |
| Reis, MA | 1 |
| Ferraz, AS | 1 |
| Saber, LT | 1 |
| Batista, ME | 1 |
| Muglia, V | 1 |
| Garcia, TM | 1 |
| Figueiredo, JF | 1 |
| Tokat, Y | 1 |
| Uslu, A | 1 |
| Ok, E | 1 |
| Tunçyürek, P | 1 |
| Celik, A | 1 |
| Yararbaş, O | 1 |
| Canawati, HN | 2 |
| el-Farra, R | 2 |
| Seymour, J | 1 |
| Shimashita, J | 1 |
| Dunn, D | 1 |
| Montgomerie, JZ | 2 |
| Vaessen, C | 1 |
| Janssen, T | 1 |
| Schulman, C | 1 |
| Gimber, EA | 1 |
| Shields, MD | 1 |
| Sapico, FL | 1 |
| Krishnaswamy, A | 1 |
| Maeder, KN | 1 |
| Guirguitzova, B | 1 |
| Chankova, D | 1 |
| Zozikov, B | 1 |
| Minkov, N | 1 |
| Well, M | 1 |
| Naber, KG | 2 |
| Kinzig-Schippers, M | 1 |
| Sörgel, F | 1 |
| Krcmery, S | 1 |
| Klimberg, IW | 1 |
| Malek, GH | 1 |
| Cox, CE | 1 |
| Patterson, AL | 1 |
| Whalen, E | 1 |
| Kowalsky, SF | 1 |
| Echols, RM | 1 |
| van der Wall, E | 1 |
| Verkooyen, RP | 1 |
| Mintjes-de Groot, J | 1 |
| Oostinga, J | 1 |
| van Dijk, A | 1 |
| Hustinx, WN | 1 |
| Verbrugh, HA | 1 |
| Alós, JI | 1 |
| Rodríguez, C | 1 |
| Amor, E | 1 |
| Gómez Garcés, JL | 1 |
| Hurley, JC | 1 |
| Louis, WJ | 1 |
| Tosolini, FA | 1 |
| Carlin, JB | 1 |
| Pedersen, SS | 1 |
| Hørbov, S | 1 |
| Biering-Sørensen, F | 1 |
| Høiby, N | 1 |
| Van Poppel, H | 3 |
| Willemen, P | 1 |
| Wegge, M | 2 |
| Kraseman, P | 1 |
| Chysky, V | 3 |
| Baert, L | 2 |
| Hellsten, S | 2 |
| Forsgren, A | 2 |
| Björk, T | 2 |
| Grabe, M | 2 |
| Dammekens, H | 1 |
| Galante, D | 1 |
| Pennucci, C | 1 |
| Barba, D | 1 |
| Brittain, DC | 2 |
| Scully, BE | 2 |
| McElrath, MJ | 2 |
| Steinman, R | 2 |
| Labthavikul, P | 2 |
| Neu, HC | 2 |
| Shearman, CP | 1 |
| Silverman, SH | 1 |
| Johnson, M | 1 |
| Young, CH | 1 |
| Farrar, DJ | 1 |
| Keighley, MR | 1 |
| Burdon, DW | 1 |
| Hullmann, R | 1 |
| Murdoch, DA | 2 |
| Badenoch, DF | 2 |
| Gatchalian, ER | 1 |
| Piccolomini, R | 1 |
| Ravagnan, G | 1 |
| Iravani, A | 1 |
| Welty, GS | 1 |
| Newton, BR | 1 |
| Richard, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Phase 3, Randomized, Multi-center, Double-blind, Double-dummy Study of Efficacy, Tolerability & Safety of Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Treatment of cUTI in Adults[NCT03357614] | Phase 3 | 1,395 participants (Actual) | Interventional | 2018-09-18 | Completed | ||
| Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery (NAUTICA): A Randomized Controlled Trial[NCT03287089] | Phase 4 | 164 participants (Actual) | Interventional | 2017-09-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Microbiologic success is defined as demonstrating <1000 CFU/mL of the baseline urpathogen by quantitative urine culture (NCT03357614)
Timeframe: Day 21 +/- 1 day
| Intervention | Participants (Count of Participants) |
|---|---|
| Sulopenem | 316 |
| Ertapenem | 343 |
Clinical success is defined as complete resolution of cUTI symptoms present at study entry and no new cUTI symptoms; microbiologic success is defined as eradication of the bacterial pathogen found at study entry (reduced to <1000 CFU/mL) (NCT03357614)
Timeframe: Day 21 +/- 1 day
| Intervention | Participants (Count of Participants) |
|---|---|
| Sulopenem | 301 |
| Ertapenem | 325 |
Compliance assessed by use of a medication diary during treatment period (NCT03287089)
Timeframe: within 30 days of surgery
| Intervention | ratio (Mean) |
|---|---|
| Nitrofurantoin | 0.95 |
| Placebo | 0.96 |
Number of participants with a urinary tract infection in the first 30 days following pelvic reconstructive surgery (NCT03287089)
Timeframe: within 30 days of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Nitrofurantoin | 15 |
| Placebo | 14 |
1 review available for ciprofloxacin and Bacteriuria
| Article | Year |
|---|---|
Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.
Topics: Adult; Aged; Bacteriuria; Ciprofloxacin; Enterobacteriaceae Infections; Female; Humans; Male; Microb | 1988 |
20 trials available for ciprofloxacin and Bacteriuria
| Article | Year |
|---|---|
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Ertapenem; Humans; Pyelonephritis; Urinary | 2023 |
Are prophylactic antibiotics necessary for urodynamic study?
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Female; Fosfomycin | 2013 |
One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; | 2009 |
Single-dose antibiotic prophylaxis for urinary catheter removal does not reduce the risk of urinary tract infection in surgical patients: a randomized double-blind placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Catheter | 2011 |
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Community-Acquired In | 2012 |
[Antibacterial prophylaxis of bacteriuria at transrectal multifocal prostatic biopsy].
Topics: Administration, Topical; Anti-Infective Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis | 2002 |
Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Diagnostic Techniques, Ur | 2006 |
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; | 2006 |
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy.
Topics: Administration, Oral; Adult; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Ci | 2007 |
Single-dose versus 3-day prophylaxis with ciprofloxacin in transurethral surgery. A clinical trial.
Topics: Bacteremia; Bacteriuria; Ciprofloxacin; Drug Administration Schedule; Humans; Male; Postoperative Co | 1993 |
[Experience with the use of ciprofloxacin in patients with acute uncomplicated cystitis].
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteriuria; Ciprofloxa | 1997 |
Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteriuria; Brazil; Candidiasis; Cause of Death | 1997 |
Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group.
Topics: Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Mal | 1999 |
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacteriuria; Cefotaxime; Cephalosporins; C | 1999 |
Prophylactic ciprofloxacin for catheter-associated urinary-tract infection.
Topics: Adult; Aged; Aged, 80 and over; Bacteriuria; Ciprofloxacin; Female; Humans; Male; Middle Aged; Prosp | 1992 |
Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder.
Topics: Bacteriuria; Ciprofloxacin; Cystoscopy; Double-Blind Method; Female; Humans; Male; Microbial Sensiti | 1990 |
Single dose, oral antibiotic cover for transurethral prostatectomy.
Topics: Administration, Oral; Aged; Bacteriuria; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Metho | 1988 |
The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Blood Bactericidal Activi | 1985 |
Oral ciprofloxacin as prophylaxis in transurethral resection of the prostate.
Topics: Bacteriuria; Ciprofloxacin; Clinical Trials as Topic; Humans; Male; Prostatectomy; Random Allocation | 1987 |
Oral ciprofloxacin as prophylaxis for optical urethrotomy.
Topics: Adult; Aged; Aged, 80 and over; Bacteriuria; Ciprofloxacin; Clinical Trials as Topic; Humans; Male; | 1987 |
42 other studies available for ciprofloxacin and Bacteriuria
| Article | Year |
|---|---|
Urosepsis and Bacteriuria in Patients Undergoing TRUS-Guided Prostate Biopsy.
Topics: Anti-Bacterial Agents; Bacteriuria; Bangladesh; Biopsy; Ciprofloxacin; Cross-Sectional Studies; Esch | 2023 |
Fluoroquinolone Use and Seasonal Patterns of Ciprofloxacin Resistance in Community-Acquired Urinary Escherichia coli Infection in a Large Urban Center.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escheric | 2020 |
The Effect of Antibiotic Prophylaxis on Post-Operative Infection in Patients Undergone Flexible Cystos-copy.
Topics: Aged; Ambulatory Care; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Cy | 2017 |
Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Asymptomatic Diseases; Bacteriuria; Biopsy, Nee | 2018 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cepha | 2018 |
Peri-operative antibiotic treatment of bacteriuria reduces early deep surgical site infections in geriatric patients with proximal femur fracture.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Cefuroxime; Cip | 2018 |
Evaluation of urinalysis parameters and antimicrobial susceptibility of uropathogens among out-patients at University of Cape Coast Hospital.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria | 2019 |
Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Bangladesh; Ciproflo | 2014 |
Predictive utility of prior positive urine cultures.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteriuria; Chicago; Ciprofloxacin; Cross | 2014 |
[Usefulness of antimicrobial prophylaxis with ciprofloxacin prior to flexible cystoscopy].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Cystoscopy; Female; | 2015 |
Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
Topics: Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Enterobacte | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion | 2015 |
Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.
Topics: Animals; Anti-Bacterial Agents; Bacteriuria; Chitosan; Ciprofloxacin; Escherichia coli Infections; F | 2017 |
Antibiotic resistance mechanisms of Escherichia coli Isolates from urinary specimens.
Topics: Bacterial Proteins; Bacteriuria; beta-Lactamases; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; | 2009 |
Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Topics: Acute Disease; Aged; Anti-Infective Agents, Urinary; Bacteremia; Bacteriuria; Ciprofloxacin; Cross-S | 2010 |
Infectious complications after transrectal ultrasound-guided prostatic biopsy. Analysis of our experience.
Topics: Aged; Anti-Bacterial Agents; Bacteriuria; Biopsy, Fine-Needle; Ciprofloxacin; Humans; Infections; Ma | 2011 |
Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti- | 2011 |
Minimum antimicrobial treatment for acute pyelonephritis.
Topics: Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Female; Humans; Pyelonephritis | 2012 |
[Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Topics: Adult; Aged; Amdinocillin; Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacter | 2003 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Co | 2004 |
Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.
Topics: Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Hemolysis; Humans; Nalidix | 2005 |
Virulence factors in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Hum | 2005 |
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy.
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Bacteriuria; Ciproflox | 2008 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cepha | 1994 |
Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
Topics: Administration, Oral; Adult; Bacterial Infections; Bacteriuria; Ciprofloxacin; Cystitis; Female; Hum | 1993 |
Surgical management of vesicoureteral reflux following renal transplantation.
Topics: Adult; Antibiotic Prophylaxis; Bacteriuria; Ciprofloxacin; Female; Humans; Kidney Transplantation; P | 1997 |
Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center.
Topics: Anti-Infective Agents; Bacteriuria; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Res | 1997 |
[Transrectal prostatic biopsy: the role of preventive measures].
Topics: Adenocarcinoma; Anti-Infective Agents; Antibiotic Prophylaxis; Anticoagulants; Bacterial Infections; | 1997 |
Bacteriuria with Escherichia coli resistant to ciprofloxacin in patients with spinal-cord injury.
Topics: Adult; Anti-Infective Agents; Bacteriuria; Case-Control Studies; Ciprofloxacin; Cross Infection; Dis | 1998 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactama | 1998 |
Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Topics: Administration, Oral; Adult; Bacteriuria; Calibration; Chromatography, High Pressure Liquid; Ciprofl | 1998 |
[Escherichia coli bacteremia resistant to ciprofloxacin].
Topics: Bacteremia; Bacteriuria; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli Infections; Hum | 1991 |
Antibiotic-induced release of endotoxin in chronically bacteriuric patients.
Topics: Anti-Bacterial Agents; Bacteriuria; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Endotox | 1991 |
Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria.
Topics: Adult; Bacteriuria; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Sp | 1990 |
Use of ciprofloxacin in patients undergoing transurethral prostatic surgery.
Topics: Bacterial Infections; Bacteriuria; Ciprofloxacin; Drug Evaluation; Humans; Male; Postoperative Compl | 1989 |
Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin.
Topics: Administration, Oral; Adult; Aged; Bacteriuria; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ps | 1986 |
Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Topics: Bacteriuria; Cinoxacin; Ciprofloxacin; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbia | 1985 |
The pharmacology of orally administered ciprofloxacin.
Topics: Administration, Oral; Adult; Bacteriuria; Ciprofloxacin; Humans; Kinetics; Male; Quinolines; Time Fa | 1985 |
Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery.
Topics: Aged; Aged, 80 and over; Bacteria; Bacteriuria; Catheters, Indwelling; Ciprofloxacin; Drug Administr | 1987 |
Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Ciprofloxacin; Humans; | 1986 |
Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Culture Media; Escherichia | 1985 |